Leta buys PBYI 243.33: The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene
Stocks recently featured in the blog include the Biogen (Nasdaq:BIIB-Free Report), Gilead (Nasdaq:GILD-Free Report), Puma Biotechnology (NYSE:PBYI-Free Report), AbbVie (NYSE:ABBV-Free Report) and Celgene (Nasdaq:CELG-Free Report). Today, Zacks is ... ...
64 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home